{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:43:11Z","timestamp":1791218591071,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,4]],"date-time":"2027-08-04T00:00:00Z","timestamp":1817337600000},"content-version":"am","delay-in-days":246,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioadv.2026.215095","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:27:27Z","timestamp":1785770847000},"page":"215095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["3D cell assemblies for controlled evaluation of response to dual agent delivery nanofibers targeting bacterial vaginosis"],"prefix":"10.1016","volume":"189","author":[{"given":"Arielle","family":"Greiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Kyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann B.","family":"Frieboes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2026.215095_bb0005","first-page":"4","article-title":"Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections","volume":"3","author":"Bautista","year":"2016","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bioadv.2026.215095_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.micpath.2018.11.046","article-title":"Bacterial vaginosis: an insight into the prevalence, alternative treatments regimen and it\u2019s associated resistance patterns","volume":"127","author":"Javed","year":"2019","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215095_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.JAA.0000526770.60197.fa","article-title":"Bacterial vaginosis: a practical review","volume":"30","author":"Bagnall","year":"2017","journal-title":"Jaapa"},{"key":"10.1016\/j.bioadv.2026.215095_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00446","article-title":"Distinct immune responses elicited from cervicovaginal epithelial cells by lactic acid and short chain fatty acids associated with optimal and non-optimal vaginal microbiota","volume":"9","author":"Delgado-Diaz","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215095_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12866-015-0608-0","article-title":"Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model","volume":"15","author":"Breshears","year":"2015","journal-title":"BMC Microbiol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215095_bb0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1099\/mic.0.034280-0","article-title":"Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes","volume":"156","author":"Patterson","year":"2010","journal-title":"Microbiology"},{"key":"10.1016\/j.bioadv.2026.215095_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.102090","article-title":"Characterization of Gardnerella vaginalis membrane vesicles reveals a role in inducing cytotoxicity in vaginal epithelial cells","volume":"61","author":"Shishpal","year":"2020","journal-title":"Anaerobe"},{"key":"10.1016\/j.bioadv.2026.215095_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jri.2014.08.005","article-title":"Gardnerella vaginalis triggers NLRP3 inflammasome recruitment in THP-1 monocytes","volume":"106","author":"Vick","year":"2014","journal-title":"J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215095_bb0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","article-title":"Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract","volume":"42","author":"Anahtar","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215095_bb0050","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/mi.2017.27","article-title":"Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition","volume":"10","author":"Hearps","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bioadv.2026.215095_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2022.963752","article-title":"The female reproductive tract microbiotas, inflammation, and gynecological conditions","volume":"4","author":"Gholiof","year":"2022","journal-title":"Front. Reprod. Health"},{"key":"10.1016\/j.bioadv.2026.215095_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119659","article-title":"Bacterial vaginosis: standard treatments and alternative strategies","volume":"587","author":"Tom\u00e1s","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2026.215095_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.addr.2015.06.008","article-title":"New strategies for local treatment of vaginal infections","volume":"92","author":"Palmeira-de-Oliveira","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2026.215095_bb0070","article-title":"The vaginal microenvironment: the physiologic role of lactobacilli","volume":"5","author":"Amabebe","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.bioadv.2026.215095_bb0075","article-title":"Development of 3D-printed vaginal devices containing metronidazole for alternative bacterial vaginosis treatment","volume":"5","author":"Utomo","year":"2023","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.bioadv.2026.215095_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213614","article-title":"Mesh and layered electrospun fiber architectures as vehicles for Lactobacillus acidophilus and Lactobacillus crispatus intended for vaginal delivery","volume":"154","author":"Minooei","year":"2023","journal-title":"Biomater. Adv."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215095_bb0085","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/acs.molpharmaceut.5b00073","article-title":"Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells","volume":"12","author":"Gu","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2026.215095_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejpb.2023.07.009","article-title":"Rapid-dissolving electrospun nanofibers for intra-vaginal antibiotic or probiotic delivery","volume":"190","author":"Minooei","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2026.215095_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejpb.2023.04.011","article-title":"Lactobacillus crispatus-loaded electrospun fibers yield viable and metabolically active bacteria that kill Gardnerella in vitro","volume":"187","author":"Mahmoud","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2026.215095_bb0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jconrel.2023.04.023","article-title":"Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application","volume":"357","author":"Kyser","year":"2023","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215095_bb0105","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s43032-021-00529-y","article-title":"Animal models and alternatives in vaginal research: a comparative review","volume":"28","author":"McCracken","year":"2021","journal-title":"Reprod. Sci."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215095_bb0110","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200872R","article-title":"Modeling ascending Ureaplasma parvum infection through the female reproductive tract using vagina-cervix-decidua-organ-on-a-chip and feto-maternal interface-organ-on-a-chip","volume":"36","author":"Tantengco","year":"2022","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215095_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s40168-022-01400-1","article-title":"Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip","volume":"10","author":"Mahajan","year":"2022","journal-title":"Microbiome"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215095_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059539","article-title":"Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis","volume":"8","author":"Gilbert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2026.215095_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.127023","article-title":"Electrospun nanofibers for antibiotic and probiotic co-delivery to target bacterial vaginosis","volume":"699","author":"Verhoeven","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215095_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/aid.2015.0006","article-title":"Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity","volume":"31","author":"Thurman","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215095_bb0135","article-title":"In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide","volume":"11","author":"O\u2019Hanlon","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215095_bb0140","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00460-13","article-title":"Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections","volume":"4","author":"Witkin","year":"2013","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.bioadv.2026.215095_bb0145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/elsc.202100040","article-title":"The pro-inflammatory response of macrophages regulated by acid degradation products of poly(lactide-co-glycolide) nanoparticles","volume":"21","author":"Ma","year":"2021","journal-title":"Eng. Life Sci."},{"issue":"sup1","key":"10.1016\/j.bioadv.2026.215095_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/17435390.2013.829590","article-title":"Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests","volume":"9","author":"Guadagnini","year":"2015","journal-title":"Nanotoxicology"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215095_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00284-022-02771-2","article-title":"Mechanistic insights into immune suppression and evasion in bacterial vaginosis","volume":"79","author":"Amabebe","year":"2022","journal-title":"Curr. Microbiol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215095_bb0160","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni0901-816","article-title":"Regulatory T cells in the control of immune pathology","volume":"2","author":"Maloy","year":"2001","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215095_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1155\/S1064744901000072","article-title":"Effect of metronidazole on the growth of vaginal lactobacilli in vitro","volume":"9","author":"Simoes","year":"2001","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.bioadv.2026.215095_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","article-title":"Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin","volume":"47","author":"Petrina","year":"2017","journal-title":"Anaerobe"},{"issue":"11","key":"10.1016\/j.bioadv.2026.215095_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080074","article-title":"Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota","volume":"8","author":"O\u2019Hanlon","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215095_bb0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ajog.2018.11.1089","article-title":"Ecological dynamics of the vaginal microbiome in relation to health and disease","volume":"220","author":"Greenbaum","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl. 1","key":"10.1016\/j.bioadv.2026.215095_bb0185","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/scrt374","article-title":"Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment","volume":"4","author":"Laronda","year":"2013","journal-title":"Stem Cell Res. Ther."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:45:14Z","timestamp":1788277514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826003936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S2772950826003936"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215095","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D cell assemblies for controlled evaluation of response to dual agent delivery nanofibers targeting bacterial vaginosis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215095"}}